Cardinal Health (NYSE:CAH) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided EPS guidance of $5.600-$5.900 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.760. The company issued revenue guidance of -.
Shares of CAH stock traded down $0.36 during trading hours on Thursday, reaching $48.78. The company’s stock had a trading volume of 2,478,704 shares, compared to its average volume of 2,537,619. The firm’s 50 day simple moving average is $49.56 and its 200-day simple moving average is $53.57. The company has a market capitalization of $13.75 billion, a price-to-earnings ratio of 12.60, a PEG ratio of 1.45 and a beta of 0.96. Cardinal Health has a fifty-two week low of $47.15 and a fifty-two week high of $62.96. The company has a quick ratio of 0.57, a current ratio of 1.12 and a debt-to-equity ratio of 3.83.
Cardinal Health (NYSE:CAH) last issued its earnings results on Monday, November 8th. The company reported $1.29 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.32 by ($0.03). The business had revenue of $43.97 billion during the quarter, compared to analyst estimates of $41.83 billion. Cardinal Health had a net margin of 0.68% and a return on equity of 89.90%. The company’s revenue for the quarter was up 12.6% compared to the same quarter last year. During the same period in the prior year, the business posted $1.51 EPS. Sell-side analysts predict that Cardinal Health will post 5.72 earnings per share for the current year.
CAH has been the subject of a number of analyst reports. TheStreet upgraded shares of Cardinal Health from a c+ rating to a b- rating in a report on Wednesday, November 10th. Evercore ISI restated a hold rating and set a $50.00 target price on shares of Cardinal Health in a research note on Friday, August 6th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Cardinal Health from $51.00 to $59.00 and gave the company a hold rating in a report on Friday, November 12th. Mizuho reduced their target price on shares of Cardinal Health from $56.00 to $53.00 and set a neutral rating on the stock in a report on Wednesday, November 10th. Finally, Bank of America lowered shares of Cardinal Health from a buy rating to an underperform rating and reduced their price objective for the stock from $69.00 to $56.00 in a research note on Thursday, August 5th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of Hold and a consensus price target of $57.10.
In other news, insider Ola M. Snow sold 10,000 shares of the stock in a transaction dated Thursday, November 18th. The shares were sold at an average price of $49.17, for a total value of $491,700.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.41% of the stock is owned by corporate insiders.
An institutional investor recently bought a new position in Cardinal Health stock. OLD Mission Capital LLC acquired a new stake in Cardinal Health, Inc. (NYSE:CAH) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 29,978 shares of the company’s stock, valued at approximately $1,407,000. Institutional investors own 84.54% of the company’s stock.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency.
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.